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Mutations in the creatine (Cr) transporter (CrT) gene lead to cerebral creatine deficiency 
syndrome-1 (CCDS1), an X-linked metabolic disorder characterized by cerebral Cr deficiency 
causing intellectual disability, seizures, movement and autistic-like behavioral disturbances, 
language and speech impairment. Since no data are available about the neural and molecular 
underpinnings of this disease, we performed a longitudinal analysis of behavioral and 
pathological alterations associated with CrT deficiency in a CCDS1 mouse model. We found 
precocious cognitive and autistic-like defects, mimicking the early key features of human 
CCDS1. Moreover, mutant mice displayed a progressive impairment of short and long-term 
declarative memory denoting an early brain aging. Pathological examination showed a 
prominent loss of GABAergic synapses, marked activation of microglia, reduction of 
hippocampal neurogenesis and accumulation of autofluorescent lipofucsin. Our data suggest 
that brain Cr depletion causes both early intellectual disability and late progressive cognitive 
decline, and identify novel targets to design intervention strategies aimed at overcoming brain 
CCDS1 alterations. 
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Introduction 
Creatine (Cr) has a fundamental role in the energy metabolism of cells, particularly in tissues with 
high-energy demand. Cr kinase (CK) catalyzes the reversible conversion of Cr and ATP to 
phosphoCr (PCr) and ADP. Most of cells, indeed, do not rely on ATP/ADP free diffusion and the 
CK/PCr/Cr system serves as energy storage for immediate regeneration of ATP and as shuttle of 
high- energy phosphates between sites of ATP production and consumption (1). In physiological 
conditions, Cr is obtained by diet and by endogenous synthesis, which involves the enzymes l-
arginine:glycineamidinotransferase (AGAT) and S-adenosyl-l-methionine:N-
guanidinoacetatemethyltransferase (GAMT). Additionally, Cr is a polar hydrophilic molecule 
unable to cross the plasma membrane and a specific Na+/Cl−- dependent transporter (Cr transporter, 
CrT) is required for Cr to enter the cells (2). 
The great relevance of Cr/PCr system for the normal functioning of brain cells is well 
supported by the recent discovery of three different pathologies characterized by defects of Cr 
metabolism that lead to primary neurological symptoms. AGAT (3) and GAMT disorders (4) are 
autosomal recessive conditions impairing Cr biosynthesis, while CrT deficiency (CCDS1) is an X- 
linked condition affecting cellular uptake of Cr (5). These disorders share the depletion of brain Cr 
and a similar clinical phenotype with intellectual disability, behavioral autistic-like abnormalities, 
language and speech disturbances, seizures and movement disorders (2, 6). Very little is known 
about Cr regulation and function in the brain. In the central nervous system, AGAT, GAMT and 
CrT are widely expressed in brain cells, including neurons, oligodendrocytes, and endothelial cells 
of the blood-brain barrier (7, 8). The lack of knowledge about the effects of Cr deficiency on 
neuronal circuits stems at least partially from the paucity of studies on animal models. Two 
germline murine models of CCDS1 and one model of GAMT deficiency are available so far (9–11), 
and they have been analyzed only in some  behavioral domains and at neurochemical level, while 
studies on AGAT-deficient mice are limited to metabolic effects of Cr deficiency (12). Learning 
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and memory deficits, impaired motor activity and Cr depletion in brain and muscles have been 
reported in GAMT and CrT models in the adult age (9–11). However, little is known about the 
presence of autistic-like behavioral features and the onset and progression of the phenotype.  
Several papers found that the disturbed energy metabolism caused by prolonged and 
sustained Cr depletion might resonate in molecular networks resulting in abnormal metabolism. 
Accordingly, the skeletal muscle of AGAT deficient mice display a marked increase of inorganic 
phosphate/bATP ratio and overall mitochondrial content, while ATP levels were reduced by nearly 
half (13). Patients with Cr deficiency syndrome are reported to have increased oxidative stress and 
reactive oxygen species (ROS)-induced apoptotic cell loss (14), whereas Cr supplementation in 
senescent mice improved neurobehavioral outcomes and prolonged median survival with a trend 
towards lower ROS (15). We speculated that the disturbed energy metabolism caused by prolonged 
and sustained Cr depletion might set in motion the precocious activation of detrimental cellular and 
molecular mechanisms typical of brain aging leading to a progressive cognitive regression. The lack 
of the antioxidant activity of Cr (16, 17) in CCDS1 might also contribute to this process (18). This 
hypothesis would explain the observation that intellectual disability of CCDS1 patients seems to 
become more pronounced with age (19). Intriguingly, our surmise could also be relevant for normal 
brain aging  as suggested by recent data showing that Cr levels are downregulated in aged human 
brain (20, 21). 
Thus, we performed a longitudinal evaluation of cognitive functions in CrT deficient mice 
and we examined various age-related brain phenotypes including neuronal degeneration, 
hippocampal neurogenesis, synaptic loss, neuroinflammation and oxidative stress. Our results show 
that reduced Cr levels accelerate the brain aging process, indicating that CCDS1 could be 
considered an age-dependent disorder and that alterations of Cr metabolism are directly involved in 
brain aging.  
 
Results 
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Reduced body weight growth in CrT
–/y
 mice 
A first clue indicating that CrT deficiency elicits age-related detrimental effects emerged from the 
general appearance of mutant animals. Mice were weighed at different ages and compared with WT 
littermates. Even though no particular problems of breeding were observed and the face of CrT–/y 
mice was normal till P40, CrT−/y animals (n = 12) showed a significantly reduced body weight 
compared to CrT+/y animals at P60, P100 and P180 (n = 13; Two way ANOVA on rank transformed 
data, p < 0.001 effect of genotype, p < 0.001 interaction between genotype and age; post hoc Holm 
Sidak method, p = 0.092 at P40, p < 0.001 in all other comparisons; Fig. S1). 
 
Age-related deterioration of cognitive functions in Cr deficiency conditions 
In  previous behavioral investigation performed at P40, we highlighted that CrT−/y mice exhibit a 
general cognitive impairment across different learning and memory tests (11). To understand 
whether a progressive deterioration of behavioral impairment is present in CrT−/y mice, we studied 
four different stages: 1. during the early brain development (postnatal day (P) 28 at the beginning of 
testing), 2. during the late brain development (P40 at the beginning of testing), 3. in the adult age 
(P100 at the beginning of testing), and 4. in the middle age (P180 at the beginning of testing). 
Interestingly, a progressive worsening of cognitive symptoms was detectable in CrT−/y mutant mice, 
suggesting that age is a key feature of Cr deficiency disease. 
Y maze. We first analyzed the performance of CrT−/y animals at P28 using the Y maze spontaneous 
alternation, which is an optimal task for probing memory in juveniles (Fig. 1a; (22)). Animals of 
both groups equally explored all the three arms of the maze. Indeed, no effect of genotype was 
detected for either the number of entries in the single arms of the maze (designated A, B, C) or the 
total number of arm entries, indicating that the exploratory disposition of mutant animals (n = 9) 
was not altered compared to WT littermates (n = 11; Two-Way ANOVA on rank transformed data, 
post hoc Holm-Sidak method, p = 0.506, p = 0.941, p = 0.276, p = 0.391 respectively, Fig. 1a). 
However, while in young WT mice alternation rate was about 60% of total arm choices, in CrT−/y 
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animals it dropped to the chance level (50%; Fig. 1b), demonstrating that CrT disruption in the 
mouse model could reproduce the early pathological phenotype of CCDS1 patients. The same 
impairment was detected at P40, P100 and P180 with CrT−/y mice performing at chance level 
whereas WT age-matched controls showed significant spontaneous alternation (t test, p < 0.01 for 
P40, p < 0.05 for P100 and P180, Fig. S2). These data also indicated that the spontaneous 
alternation paradigm cannot reveal age-dependent cognitive decline in CrT mutants because of the 
ceiling effect in the arm alternation deficit masking the effect of the age variable. 
Object recognition test (ORT). We assessed declarative memory abilities in the ORT, a test based 
on the spontaneous tendency of rodents to spend more time exploring a novel object than a familiar 
one. No difference in short-term recognition memory between P40 CrT−/y mice (n = 9) and age-
matched WT animals (n = 7) could be detected (t-test, p = 0.285). In contrast, the discrimination 
index at 24 h was significantly lower in mutant mice, indicating that their capacity to recall the 
familiar object was impaired (t-test, p < 0.05; Fig. 2a). This memory deficit became more 
pronounced two months later (CrT−/y n = 11, CrT+/y n = 10; P100, t-test, p < 0.01 at 24h; Fig. 2b), 
and eventually affecting both short and long-term memories at P180. Indeed, at P180 CrT−/y mice 
showed a marked memory deficit both at 1- and 24-h interval between the sample and the test phase 
with respect to CrT+/y mice (CrT−/y n = 10, CrT+/y n = 9; t-test, p < 0.05 for both comparisons; Fig. 
2c), indicating that the longer the time during which neural circuits are forced to work without Cr 
energy buffer the worse the cognitive performance of CrT−/y animals. 
Morris water maze (MWM). We further assessed memory abilities in the MWM, a cognitive 
paradigm that allows testing spatial learning and memory. The probe test highlighted a spatial 
memory impairment in Cr deficient mice at all the different ages tested: WT animals, indeed, spent 
significantly longer time in the quadrant where the platform was located during the training days 
(NE*; Two-Way RM ANOVA, post hoc Holm-Sidak method, p < 0.05 for all comparisons), while 
mutant mice did not remember the location of the hidden platform and equally explored the four 
quadrants of the maze (Two-Way RM ANOVA, post hoc Holm-Sidak method; Fig. S3). 
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The results obtained in the training phase of the MWM test, however, showed a clear 
progression of cognitive deficits in CrT−/y mice. Since a main effect of genotype was found on mean 
swimming speed recorded all along the training phase at the different ages tested (t-test, p < 0.05 
(P40); Mann-Whitney Rank Sum test, p < 0.05 (P100); t-test, p < 0.01 (P180); Fig. S4), we 
analyzed the length of path covered to find the submerged platform. At P40 CrT−/y animals (n = 12) 
were able to learn the task as well as their age-matched WT controls (n = 10): although the mean 
distance to locate the submerged platform on the last three days of training was longer in mutant 
mice compared to CrT+/y littermates (t test, p < 0.05), they exhibited a progressive reduction of the 
path length similar to WT littermates (Two-Way RM ANOVA, p = 0.084 effect of genotype) with a 
significant difference between the two groups only at the day 5 of training (post hoc Holm-Sidak 
method, p < 0.05; Fig. 3a). The same was true in P100 animals (CrT−/y: n = 8, CrT+/y: n = 7; Two-
Way RM ANOVA on rank transformed data, p = 0.132 effect of genotype, post hoc Holm-Sidak 
method, p < 0.05 at day 5; Fig. 3b). In contrast, CrT−/y mice (n = 7) were significantly slower 
learners with respect to age-matched WT mice (n = 9) at P180 so much so that the distance to locate 
the platform was different between the two groups at days 3, 4, 5 and 6 of training (Two-Way RM 
ANOVA on rank transformed data, genotype, p < 0.001, interaction between genotype and day p < 
0.001; post hoc Holm-Sidak method, p < 0.05 for day 3 and 6, p < 0.01 for day 4 and 5; Fig. 3c).  
To further corroborate the hypothesis of a premature cognitive decline in CrT null mice, we 
compared the performance in the MWM of P180 CrT−/y animals and one-year old wild-type mice (n 
= 4). The mean distance to locate the platform on the last three days of training (t-test, p = 0.968; 
Fig. S5a) and the probe test revealed a similar learning and memory impairment in these two 
experimental groups (Two-Way RM ANOVA, p = 0.479; Fig. S5b). 
  
Emotional phenotype is not altered in CrT mutant animals 
To rule out the possibility that significant differences in cognitive capacities reflect changes in the 
ability to cope with stress in challenging task conditions, we analyzed general activity and anxiety-
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related behavior of CrT−/y and CrT+/y mice in the open field arena at the different ages used for 
cognitive assessment. We found that the time spent by CrT−/y mutant mice (n = 12 for P40 and 
P100, n = 11 for P180) in both the central and peripheral portion of the apparatus was not different 
from that recorded for WT animals (n = 13 for P40 and P100, n = 11 for P180) at any of the time 
point tested (Two Way ANOVA, post hoc Holm-Sidak method, p = 0.725 (P40), p = 0.508 (P100) 
and p = 0.348 (P180)), indicating that the vulnerability to stress and anxiety responses are not 
sensitive to CrT deletion and excluding the hypothesis that the progression of cognitive deficit 
might be related to altered emotionality (Fig. S6). 
 
CrT
–/y
 mice exhibit increased repetitive and stereotyped behavior 
Since the clinical picture of CCDS1 patients include multiple traits linked to autism spectrum 
disorders (ASDs), we also examined social behavior in CrT null mice. Although we used two 
different social interaction paradigms, we detected no abnormalities in CrT–/y mice at P180. In the 
social preference test, indeed, both CrT–/y (n = 8) and CrT+/y (n = 6) animals spent significantly 
more time exploring the wire cup housing the conspecific subject (Mann-Whitney Rank Sum test, p 
= 0.662; Fig. 4a). Similarly, the discrimination index measured in the social novelty task did not 
differ between mutant and WT mice (t-test, p = 0.784; Fig. 4a). 
        The second core ASD symptom domain includes repetitive and stereotyped movements, 
routines, and rituals (23) and several mouse lines with ASD-associated mutations exhibit enhanced 
learning on the accelerating rotarod, a task that requires formation and consolidation of a repetitive 
motor routine (24). Thus, we tested rotarod abilities of CrT–/y (n = 12 for P40, n = 11 for P100 and n 
= 9 for P180) and CrT+/y (n = 13 for P40 and P100, n = 11 for P180) animals, with the speed of 
rotation accelerating from 4 to 40 rpm over 600 s. The performance of CrT–/y mutant mice diverged 
from that of wild-type mice, with a significant increase of fall latency from the drum at all ages 
tested (Two Way ANOVA, effect of genotype p < 0.001, post hoc Holm Sidak method, p < 0.01 at 
P40 and P100, p < 0.05 at P180; Fig. 4b).  We next examined self-grooming, another stereotyped 
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behavior in mice (25). While no difference was present at P40 (CrT–/y, n = 9; CrT+/y, n = 7; Two 
Way ANOVA on rank transformed data, post hoc Holm Sidak method, p = 0.912) CrT null mice 
spent about threefold as much time grooming themselves as littermate WT mice at P180 (CrT–/y, n 
= 7; CrT+/y, n = 11; p < 0.01; Fig. 4c).  
 
CrT deletion leads to a widespread Cr reduction in young and adult mice 
To understand whether the progression of cognitive deficits in CrT−/y mice was due to a gradual 
reduction of brain Cr content, we measured Cr levels in various tissues in 1-month- and 6-month-
old animals using GC/MS. At both ages, we observed a significant reduction of Cr in the brain 
(both cerebral cortex and hippocampus; Two Way ANOVA on rank transformed data, post hoc 
Holm-Sidak method, p < 0.001), muscle (p < 0.001), heart (p < 0.001) and kidney (p < 0.05) of 
CrT−/y mice with respect to wild-type (WT) littermates (n = 4/tissue for each group; Table 1). 
Importantly, no difference was detected in Cr levels measured in the different tissues between P30 
and P180 CrT−/y mice, except for the muscle: a Three way ANOVA on rank transformed data 
analysis revealed a significant interaction (p < 0.001) between genotype and age only at level of 
muscular tissue with a significant reduction of Cr levels in P180 CrT−/y mice (post hoc Holm-Sidak 
method, p < 0.001). A moderate change in GAA levels was observed in some tissues (Table 2) 
suggesting that Cr deficiency leads to a compensatory attempt by upregulating Cr biosynthesis. 
Also in this case GAA content measured in P180 animals reproduced the levels reported in younger 
tissues: a Three way ANOVA on rank transformed data revealed a significant interaction (p < 
0.001) between genotype and age only at level of muscular tissue, but this analysis only stressed a 
significant reduction of GAA levels in P180 CrT−/y (post hoc Holm-Sidak method, p < 0.05) and 
WT mice (p < 0.001). These results allow rejecting the hypothesis that higher GAA toxicity could 
underlie the age-related decline of cognitive functions in CrT−/y animals. 
 
Morphological characterization of neural circuits in CrT
−/y
 mice 
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The morpho-functional organization of neural circuits in mice carrying CrT mutations has never 
been studied so far. Thus, we have investigated whether the accelerated decline of learning and 
memory functions in CrT-deficient mice was accompanied by pathological changes in brain 
morphology. The cerebral cortex and the hippocampus were analyzed because they are strictly 
involved with the symptoms caused by CrT deficiency in mice and in humans. In the same animals 
subjected to behavioral characterization, we first evaluated the neuroanatomical architecture of 
prefrontal (PFC) and cingulate cortex (ACC) of P180 mice (n = 6 for both groups). Cortical 
thickness and neuronal cell density was estimated on NeuN stained sections. No difference in the 
cortical thickness (t-test, p = 0.785 for PFC and p = 0.880 for ACC; Fig. S6) and neuronal density 
across cortical layers was observed in mutant animals  (Two Way ANOVA, p = 0.683 for PFC; 
Two Way ANOVA on rank transformed data, p = 0.146 for ACC; Fig. S7). 
 
Loss of GABAergic synapses in the cerebral cortex of CrT
−/y
 mice 
Since synaptic dysfunction is a feature commonly observed in normal aging and neurodegenerative 
disorders likely contributing to pathology progression (26), we analyzed the synaptic punctate 
expression of vGlut1 and vGAT, respectively as synaptic markers of excitatory and inhibitory 
neurons, in the cerebral cortex of CrT−/y mice. While excitatory synapses were not affected by Cr 
deficiency (n = 6 for both groups; Mann-Whitney Rank Sum test, p = 0.792 for PFC; t-test, p = 
0.340 for ACC; Fig. 5a), we detected a prominent loss of vGAT staining both in PFC and ACC, 
suggesting a specific contribution of GABAergic synaptic alterations to the neuropathological 
phenotype of CCDS1 (n = 9 for CrT−/y group, n = 8 CrT+/y group; t-test, p < 0.05 for both 
comparisons; Fig. 5b). Importantly, the loss of vGAT-positive  synapses overspread all the cortical 
layers. These results are also consistent with previous studies on CCDS1 patients exhibiting 
evidence for an epileptic phenotype (27) that could be predictive of a dysfunction of inhibitory 
interneurons. 
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Microglial cell dysregulation in the Cr deficient brain 
Since aberrant microglia activation is one of the main pathological hallmarks of brain aging (28, 
29), we have also evaluated Iba-1 expression as a marker of possible morphological changes of 
microglia in the cerebral cortex (PFC) and the hippocampus (HP) of mutant mice. During aging 
microglia cells undergo morphological changes towards a reactive phenotype with short, thickened 
and less ramified processes (30). We found a strong increase of activated microglial cells in the 
brain of CrT null animals as compared to wild-type controls (n = 8 for both groups), with a parallel 
reduction of resting cells (Two Way ANOVA, post hoc Holm Sidak method, p < 0.01 for PFC and 
p < 0.05 for HP; Fig. 6a,b), indicating that the metabolic deficit caused by Cr deficiency leads to a 
dysfunction of brain-immune cells interactions and to a neuroinflammatory state that can contribute 
to the cognitive decline reported in CrT−/y mice. 
 
Reduced neurogenesis and enhanced lipofuscin accumulation in the hippocampus of  CrT
−/y
 
mice 
It is well-known that the rate of neurogenesis declines dramatically with age and dysregulation of 
hippocampal neurogenesis is an important mechanism underlying the cognitive impairment 
associated with normal aging (31). In order to investigate whether CrT deficiency could affect 
hippocampal structure and impinge on the neurogenesis process, we examined neuronal 
proliferation through Ki67 labelling in the dentate gyrus (DG) of wild type and CrT−/y mice (n = 6 
for both groups). Stereological analysis first revealed that the hippocampal volume of mutant 
animals was markedly reduced with respect to that measured in control mice (t-test, p < 0.05; Fig. 
7a). Accordingly, the number of Ki67-positive cell was significantly lower in the DG of CrT−/y 
animal at P180, with approximately 30% reduction (t-test, p < 0.01; Fig. 7b,d). We also evaluated 
the number of immature neurons in hippocampal DG using the neuroblast marker doublecortin 
(DCX). DCX-positive cells were also significantly reduced in CrT null mice DG (t-test, p < 0.001; 
Page 11 of 55 Human Molecular Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 12
Fig. 7c,e), demonstrating the impairment of adult hippocampal neurogenesis and suggesting another 
cellular substrate of the cognitive deficit present in the CrT null model. 
Another characteristic neuropathological finding in CrT mice was the massive accumulation 
of autofluorescent material (lipofuscin). Lipofuscin is a lipopigment consisting of aggregated 
products of lysosomal degradation, including oxidized and misfolded proteins, lipids, defective 
mitochondria and metal ions (32). We observed a marked accumulation of autofluorescent 
lipofuscin throughout the brain, but the most prominent autofluorescent signal was seen in the DG 
hippocampal region. Lipofuscin deposition and accumulation within the hippocampal neurons is a 
marker of cellular senescence (33); (34).  Thus, we compared the area of lipofuscin granules in the 
brain cells of 6-month-old CrT−/y (n = 6) mice and their CrT+/y siblings (n = 5). The accumulation of 
lipofuscin was significantly exacerbated in the hippocampal DG of CrT−/y animals at P180 (t-test, p 
< 0.05, Fig. 7f,g).   
 
A conditional brain-specific model of CCDS1 recapitulates the phenotype displayed by CrT
−/y
 
mice 
Since CrT−/y mice with ubiquitous deletion of the CrT gene showed a marked Cr depletion also in 
peripheral tissues, we analyzed a novel mouse model in which a conditional CrT allele was deleted 
in postmitotic neurons, glial cells and BBB endothelial cells by using the Nestin promoter to drive 
Cre-recombinase expression (35; nes-CrT mice).  
As expected, biochemical analysis in these mice highlighted a depletion of Cr (and a parallel 
increase of GAA), similar to that of the null CrT mouse, totally restricted to  
the brain tissue, with peripheral tissues being not affected (Table 3, 4). Importantly, we also 
observed that CrTfl/y animals not expressing Cre recombinase did not present a hypomorph 
phenotype, with normal levels of Cr in different tissues (Table 3, 4). Behavioral investigation 
highlighted that mutant (nes-CrT-/y) animals showed an impaired performance in the object 
recognition test (Fig. 8a) and a lower alternation rate in the Y maze (Fig. 8b), demonstrating an 
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impairment of both declarative and working memory reminiscent of the deficit described in the 
ubiquitary model. More specifically, at P180 nes-CrT−/y mice displayed an impaired discrimination 
index with respect to nes-CrT+/y mice both at 1- and 24-h interval between the sample and the test 
phase (nes-CrT−/y n = 6, nes- CrT+/y n = 8; t-test, p < 0.05 for both comparisons; Fig. 8a). In the Y 
maze, the alternation rate of nes-CrT-/y mice (n = 6) was about 10% lower of that reported for nes-
CrT+/y animals (n = 6; t-test, p < 0.05; Fig. 8b).  We also investigated whether selective CrT 
deficiency could affect hippocampal neurogenesis. Stereological analysis revealed that the number 
of Ki67-positive cell was significantly lower in the DG of nes-CrT−/y animal at P180 compared to 
age-matched controls (n = 6 for both group; t-test, p < 0.05; Fig. 8c). These results prove that the 
lack of CrT protein exclusively restricted to brain cells is sufficient to recapitulate the cognitive and 
cellular defects displayed by global knock-out mice. 
 
Discussion 
CCDS1 is known to cause brain Cr depletion and several neurological deficits, but nothing is 
known about the neurobiological basis of this disease. We performed the first analysis of 
morphological, cellular and behavioral impairments in a CCDS1 mouse model. The results report 
the earliest cognitive phenotype observed so far in CCDS1 mice, and a novel behavioral phenotype 
consisting in enhanced stereotypies. Moreover, we found that phenotypes associated with brain 
aging, including a progressive learning and memory deterioration, synaptic loss, microglial cell 
activation, neurogenesis impairment and lipofuscin deposition already occurs in adult animals. The 
significant differences in learning and memory performance of CrT−/y mice reflected changes in 
cognitive abilities per se: indeed, the open field test revealed that mutant mice display anxiety 
levels in the range of normal values, indicating that their capacity to cope with stressful conditions 
of behavioral tests is not altered. 
It is essential noticing that the main organ affected in human CCDS1 is the brain, with 
patients showing normal cardiac function and unaltered Cr levels in the muscle (2). In contrast, 
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CrT−/y mice displayed a marked reduction of Cr also in peripheral tissues. To understand whether 
the cognitive phenotype observed in CrT null mice depends on brain CrT deletion or if peripheral 
factors may also play a key role, we analyzed  learning and memory in a mouse model in which 
CrT deletion was restricted to the brain. Our results demonstrate that Cr brain-specific depletion is 
sufficient to cause a cognitive impairment indistinguishable from that of mice with ubiquitous CrT 
deletion. 
 
The role of Cr deficiency in aging process: novel mechanistic insights 
An important question raised by the premature aging of CrT−/y mice concerns the role of Cr 
deficiency in the aging process. It is worth noting that the cognitive regression of CrT−/y animals 
was not paralleled by either a decrease of Cr levels in the brain tissue or a rise of GAA toxicity, 
suggesting that the prolonged lack of Cr energy buffer may set in motion cellular compensatory 
mechanisms leading to the gradual shutdown of brain function. We detected a significant reduction 
of Cr levels in P180 CrT−/y mice with respect to P30 CrT null mice only at level of muscular tissue, 
indicating that the compensatory upregulation of Cr biosynthesis in the muscle declines with age. 
Despite the ubiquitary pattern of CrT deletion, only few CCDS1 patients displayed an alteration of 
muscular Cr levels and strength (36). Our results raise the possibility that a muscular phenotype 
could occur also in patients later in life. 
We have considered the possibility that the accelerated decline in cognitive performance in 
mature CrT−/y animals could be related to the documented neuroprotective (e.g., (15, 36, 38)) and 
anti-apoptotic effects of Cr (39). However, when we examined neuronal density in the cerebral 
cortex, we did not detect any significant reduction in the number of NeuN-positive cells either in 
the PFC or in the ACC. In contrast, we found a marked impairment of hippocampal neurogenesis in 
the brain of mature CrT−/y mice. This was assessed by observing significantly reduced numbers of 
Ki67-positive proliferating cells along with DCX-positive immature neurons in the hippocampal 
DG region. These results are consistent with the notion that the creation of new neurons is an 
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energetically expensive process (40) and that the hippocampus is particularly vulnerable to 
metabolic alterations (41). Since adult hippocampal neurogenesis plays a vital role in maintaining 
normal cognitive processing (41, 42), an impairment of this process could conceivably compromise 
hippocampal function and represent a key substrate of the cognitive defects seen in CrT−/y mice. 
Accordingly, most studies indicate a correlation between a compromised neurogenic niche and 
impaired performance in hippocampus-dependent cognitive tasks in aged mice (31). 
In addition, we observed that long-term Cr deficiency induce a more subtle and specific 
reorganization of neuronal circuits consisting in significantly lower expression of the vescicular 
GABA transporter. This alteration, which has been detected in two brain regions fundamentally 
involved in the processing of learning and memory tasks such as the PFC and the ACC, could be 
mirrored by a significant dysfunction of synaptic activity leading to increased cognitive frailty. It 
has been reported, indeed, that alterations in inhibitory interneurons contribute to cognitive deficits 
associated with aging and neurological diseases (43, 44). 
One of the principal findings of this work is the demonstration that neuroinflammation plays 
a critical role in the progression of CrT disorder. It is apparent that Cr deficiency causes an aberrant 
activation of microglial cells in the brain of mature CrT−/y animals and activated microglia may 
release a number of cytokines and chemokines, which in turn activate many proinflammatory signal 
transduction pathways. It is known that co-activation of proinflammatory and cytotoxic products 
during neuroinflammation process are detrimental to neurons and may alter synaptic proteins (45). 
Several studies, indeed, showed a significant downregulation of protein and mRNA levels of 
synaptic markers in animal models of neuroinflammation such as a non-infectious rat model of 
HIV-1 and rats treated with a high dose of lipopolysaccharide (46, 47). Recent evidence 
demonstrates that neuroinflammation also negatively affects hippocampal neurogenesis (48, 49). 
We could hypothesize that activated microglia-neuron crosstalk have detrimental effects on 
hippocampal neurogenesis and brain synaptic connectivity in CrT−/y animals. Thus, the 
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dysregulation of microglial behavior appears to be a critical component of the negative progression 
of CrT deficiency pathology. 
A possible trigger of neuroinflammation is the increased concentration of damaged 
macromolecules and protein aggregates as a result of an increase in oxidative stress as well as of 
mitochondrial dysfunction leading to excessive generation of reactive oxygen species (ROS) and 
oxidative damage to lipids, proteins and DNA. The Cr/PCr system is strongly implicated in cellular 
bioenergetic function and several studies have revealed a correlation between Cr levels and 
intracellular ROS inasmuch Cr exhibits antioxidant activity through either direct interaction with 
oxidant species or metabolic action conferring antioxidant protection (16, 17). Accordingly, we 
found an enhanced accumulation of lipofuscin in the brain of CrT−/y mice that could be the result of 
increased oxidative damage (50). The presence of lipofuscin can also influence important cellular 
processes, such as autophagy, by inhibiting the fusion between autophagosomes and lysosomes, 
thus further exacerbating the accumulation of degradation products and cognitive impairment (51). 
Since our morphological analysis of mutant brain was all performed in adult animals, future 
studies will need to check the developmental profile of markers modifications to better dissect 
cellular defects underlying the onset and progression of the pathological behavioral phenotype in 
CrT null mice. 
 
Impact on CCDS1 patients 
Present results have demonstrated that CrT null mice undergo to an early onset of brain aging. One 
fundamental conclusion emerging from this work is that CCDS1 is a metabolic disorder associated 
with early brain aging and that age should be a key factor to deal with in the clinical evaluation of 
patients. It has been previously reported that patient intellectual disability becomes more 
pronounced with age (6), but longitudinal studies in patients are totally lacking and little is known 
about the progression of the disease. 
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In addition, our CrT mouse model allowed us to discover alterations of cellular and 
molecular mechanisms that play a pivotal role in the generation of the CCDS1 neurological 
phenotype. Mutant mice displayed alteration of GABAergic system, reduction of hippocampal 
neurogenesis, marked activation of microglia, and altered oxidative metabolism, leading to a 
general cognitive deterioration progressively worsening with age. This knowledge opens the 
important possibility to design targeted-drug intervention protocols aimed at overcoming brain 
alterations. If we could rescue brain alterations underlying CCDS1, indeed, both clinical and 
behavioral amelioration should be achieved. The use of non-invasive methods for behavioral 
assessment suitable for longitudinal analysis and the morphological characterization of brain 
alterations in CrT−/y mice set a firm background for translational studies using this model, providing 
normative data and protocols necessary to validate potential treatment strategies prior to launching 
costly clinical trials. Finally, our data also suggest that CrT−/y animals may serve as a useful model 
for exploring the mechanisms of age-related damage in the brain. A large number of 
neurodevelopmental and neurological disorders, including Down syndrome, Batten disease, 
progranulin deficiency, brain iron dysregulation, have been associated with early brain aging (52–
55). Thus, a better understanding of factors that accelerate age-related deterioration of cognitive 
performance is critical both for improving the likelihood for successful aging and for revealing 
pathological changes of translational value.   
Material and methods 
Animals 
As CrT deficiency is an X-linked pathology, male mice were selected for this study. CrT-/y and 
CrT+/y mice on a C57BL/6 J background were generated as described previously (11). Animals 
were maintained at 22°C under a 12-h light–dark cycle (average illumination levels of 1.2 cd/m2). 
Food (4RF25 GLP Certificate, Mucedola) and water were available ad libitum. To target CrT 
deletion to neuronal and glial cells of the central nervous system we used a mouse (35) expressing 
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Cre recombinase under the Nestin promoter (Nestin:Cre). CrT+/fl females were crossed with 
Nestin:Cre male mice to generate a mouse line carrying the floxed CrT and Nestin:Cre alleles. Mice 
with three genotypes were used as experimental animals: mice carrying the brain specific deletion 
of CrT (Nestin:Cre-CrT-/y, nes-CrT-/y), mice expressing the floxed allele but not Cre-recombinase 
(CrTfl/y), and mice expressing Cre-recombinase but not carrying the floxed allele (Nestin:Cre-
CrT+/y, nes-CrT+/y). These genotypes were obtained in the same litters. Since CrTfl/y mice did not 
display any difference in Cr levels with respect to nes-CrT+/y animals, we performed behavioral and 
anatomical investigation only in the other two experimental groups. All experiments were carried 
out in accordance with the European Communities Council Directive of 24 November 1986 
(86/609/EEC) and were approved by the Italian Ministry of Health (authorization number 
259/2016-PR). 
Detection of Slc6a8 mutation by PCR 
Genomic DNA was isolated from mouse tail using a kit, and the protocol suggested by the 
manufacturer (DNeasy Blood & Tissue Kit, Qiagen, USA). DNA was amplified for CrT mutant and 
wild-type (WT) allele using a standard PCR protocol with the following primers: 
F:AGGTTTCCTCAGGTTATAGAGA; R:CCCTAGGTGTATCTAACATCT; R1: 
TCGTGGTATCGTTATGCGCC. Primers for Cre recombinase expression were: F: 
AACGCACTGATTTCGACC; R: CAACACCATTTTTTCTGACCC. For PCR amplification we 
used 300 ng of DNA in a 25 µL reaction volume containing 0.2 mM of each dNTP, 2 µM of F 
primer, 1 µM of R, 1 µM of R1 primer and 0.5 U/µL Red Taq DNA polymerase (Sigma-Aldrich, 
Italy). The PCR conditions were as follows: 94°C for 4 min followed by 37 cycles at 94°C for 30 s, 
58°C for 30 s, 72°C for 40 s and a final extension at 72°C for 7 min. Amplicons were separated 
using 2% agarose gel and visualized under UV light after staining with Green Gel Plus (Fisher 
Molecular Biology, Rome, Italy). Amplicon sizes were: WT allele = 462 bp; mutant allele = 371 
bp; Cre allele = 310 bp.  
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Behavioral testing 
The testing order for behavioral assessment performed in the same animals consisted of: open field 
(1 day duration), object recognition test (ORT) at 1h (1 day), ORT at 24h (3 days), Y maze (1 day), 
Morris water maze (MWM) with hidden platform (7 days), rotarod (1 day), three chamber social 
test (1 day) and self-grooming (1 day). The mice were tested on one task at a time with the next 
behavioral test starting at least 1 days after the completion of the previous one. While open field, 
ORT, Y maze, rotarod and self-grooming were longitudinally administered to the same animals, 
MWM was performed in separate groups of animals at the different ages tested. Y maze has been 
also used to test cognitive functions in juvenile animals (P28). Social behavior has been tested only 
in 6-month-old animals. In order to reduce the circadian effects, behavioral tests were performed 
during the same time interval each day (14:00–18:00h; light phase). All behavioral tests were 
conducted in blind with respect to the genotype of animals. Animals not performing the task 
required were excluded from the analysis. Mice were weighed at the end of experiments. 
Open field and object recognition test (ORT) 
The apparatus consisted of a square arena (60 × 60 × 30 cm) constructed in poly(vinyl chloride) 
with black walls and a white floor. The mice received one session of 10-min duration in the empty 
arena to habituate them to the apparatus and test room. Animal position was continuously recorded 
by a video tracking system (Noldus Ethovision XT). In the recording software an area 
corresponding to the center of the arena (a central square 30 × 30 cm), and a peripheral region 
(corresponding to the remaining portion of the arena) were defined. The total movement of the 
animal and the time spent in the center or in the periphery area were automatically computed. 
Mouse activity during this habituation session was analyzed for evaluating the behavior in the open 
field arena. The ORT consisted of two phases: sample and testing phase. During the sample phase, 
two identical objects were placed in diagonally opposite corners of the arena, approximately 6 cm 
Page 19 of 55 Human Molecular Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 20
from the walls, and mice were allowed 10 min to explore the objects, then they were returned to 
their cage. The objects to be discriminated were made of plastic, metal, or glass material and were 
too heavy to be displaced by the mice. The testing phase was performed either 1h or 24h after the 
sample phase. One of the two familiar objects was replaced with a new one, while the other object 
was replaced by an identical copy. The objects were placed in the same locations as the previous 
ones. The mice were allowed to explore objects for 5 min. To avoid possible preferences for one of 
two objects, the choice of the new and old object and the position of the new one were randomized 
among animals. The amount of time spent exploring each object (nose sniffing and head orientation 
within <1.0 cm) was recorded and evaluated by the experimenter blind to the mouse genotype. 
Arena and objects were cleaned with 10% ethanol between trials to stop the build-up of olfactory 
cues. Mice exploring the two objects for less than 10 s during the sample phase were excluded from 
testing. A discrimination index was computed as DI = (T new - T old)/(T new + T old), where T new is 
the time spent exploring the new object, and T old is the time spent exploring the old one (11). 
Y maze spontaneous alternation 
We used a Y-shaped maze with three symmetrical grey solid plastic arms at a 120-degree angle (26 
cm length, 10 cm width, and 15 cm height). Mice were placed in the center of the maze and allowed 
to freely explore the maze for 8 minutes. The apparatus was cleaned with 10% ethanol between 
trials to avoid the build-up of odor traces. All sessions were video-recorded (Noldus Ethovision XT) 
for offline blind analysis. The arm entry was defined as all four limbs within the arm. A triad was 
defined as a set of three arm entries, when each entry was to a different arm of the maze. The 
number of arm entries and the number of triads were recorded in order to calculate the alternation 
percentage (generated by dividing the number of triads by the number of possible alternations and 
then multiplying by 100; (11). 
Morris water maze 
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Mice were trained for four trials per day and for a total of 7 days (11) in a circular water tank, made 
from grey polypropylene (diameter, 120 cm; height, 40 cm), filled to a depth of 25 cm with water 
(23°C) rendered opaque by the addition of a non-toxic white paint. Four positions around the edge 
of the tank were arbitrarily designated North (N), South (S), East (E), and West (W), which 
provided four alternative start positions and also defined the division of the tank into four 
quadrants, i.e., NE, SE, SW, and NW. A square clear Perspex escape platform (11 × 11 cm) was 
submerged 0.5 cm below the water surface and placed at the midpoint of one of the four quadrants. 
The hidden platform remained in the same quadrant during training, while the start positions (N, S, 
E, or W) were randomized across trials. The pool was situated in a room containing extra-maze 
cues that provide specific visual reference points for locating the submerged platform. Mice were 
allowed up to 60 s to locate the escape platform, and their swimming paths were automatically 
recorded by the Noldus Ethovision system. If the mouse failed to reach the platform within 60 s, the 
trial was terminated, and the mouse was guided onto the platform for 15 s. On the last trial of the 
last training day, mice received a probe trial, during which the escape platform was removed from 
the tank and the swimming paths were recorded over 60 s while mice searched for the missing 
platform. The swimming paths were recorded and analyzed with the Noldus Ethovision system. 
 
Rotarod 
Motor coordination and abilities were assessed using the rotarod test as described in (56). Animals 
were placed on a drum with increasing rotation speed from 4 to 40 rpm. The time spent on the drum 
was recorded by an automated unit, which stops as the mouse fall. Motor abilities were assessed by 
conducting the test for four consecutive times with an interval of 5 min in the same day. 
 
Three-chamber social test 
The three-chamber paradigm test has been successfully employed to study sociability and 
preference for social novelty in several mutant mouse lines. "Sociability" is defined as propensity to 
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spend time with a conspecific, as compared to time spent alone in an identical but empty chamber; 
"preference for social novelty" is defined as propensity to spend time with a new mouse rather than 
with a familiar mouse (57). We adapted the protocol reported in (58). The apparatus consisted in a 
rectangular, three-chamber box made from clear Plexiglas (72 cm wide ×  50 cm length × 33 high). 
Each chamber is 24 x 50 cm and the dividing walls are made from clear Plexiglas, with an open 
middle section, which allows free access to each chamber. Two identical, wire cup-like containers 
with removable lids were placed inside the apparatus, one in each side chamber. Each container was 
made of metal wires allowing for air exchange between the interior and exterior of the cup but small 
enough to prevent direct physical interactions between the inside animal and the subject mouse. 
Two classes of mouse were used in this experiment, one acting as a control, naïve animal, while the 
other is the test subject. The control mouse was a mouse of the same background, age, gender and 
weight, without any prior contact with the subject mouse. Two control mice were required per 
experiment, one used for session I (Stranger 1) and another for session II (Stranger 2). The same 
control mice were used between trials. Control mice were gradually habituated to wire-cup housing 
in the three-chamber box for 4 days (30 min per day) before the starting of test session. After 10 
min of habituation in the arena with empty wire cups of the subject mouse, we placed Stranger 1 
inside one of the wire cups. The subject mice were allowed to explore each of the three chambers 
for 10 min (session I). Animal position was continuously recorded by a video tracking system 
(Noldus Ethovision XT). The amount of time spent exploring each wire cup was recorded and 
evaluated by the experimenter blind to the mouse genotype. A discrimination index was computed 
as DI = (Tsoc - Tobj)/(Tsoc + Tobj), where T soc is the time spent exploring the cup housing the 
Stranger 1, and Tobj is the time spent exploring the other cup. In session II we placed Stranger 2 
inside the wire cup in the opposite side chamber. Duration of session II was 10 min and we 
calculated the same DI described above, differentiating the exploration time of the subject mouse 
between Stranger 1 and Stranger 2. The placement of Stranger 1 and Stranger 2 in the left or right 
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side of the box was randomized between trials. Arena and wire cups were cleaned with 10% ethanol 
between trials to prevent olfactory cue bias. 
 
Self-grooming 
Mice were scored for spontaneous grooming behaviors as described earlier (59). Each mouse was 
placed individually into a clean, empty, standard mouse cage (27 length × 20 cm wide × 15 cm 
high) without bedding. Animal behaviors were videotaped for 20 min. After a 10-min habituation 
period in the test cage, each mouse was scored with a stopwatch for 10 min for cumulative time 
spent grooming all body regions. 
Biochemical analysis 
For Cr and GAA assay, mouse tissues, immediately frozen on dry ice and stored at -80°C until the 
analysis, were homogenized in 0.7 ml PBS buffer (Sigma-Aldrich, Italy) at 4°C using a ultrasonic 
disruptor (Microson Heat System, NY, USA) for brain or a glass manual homogenizer (VWR, Italy) 
for kidney, heart and muscle. After centrifugation (600 × g for 10 min at 4°C) an aliquot of the 
homogenate (50 µl) was assayed for protein content and the supernatant used for Cr assay as 
previously described (60). Briefly, 50 µl of saturated sodium hydrogen carbonate and 50 µl of a 
mixture containing 2- phenylbutyric acid (I.S.) in toluene (6.09 mmol/l; Sigma-Aldrich, Italy) were 
added to 200 µl of homogenate or to 100 µl of serum and urine, respectively. After adding 1 ml of 
toluene and 50 µl of hexafluoro-2,4-pentanedione (Sigma-Aldrich, Italy) to form bis-
trifluoromethyl- pyrimidine derivatives, the mixture was stirred overnight at 80°C. The organic 
layer was centrifuged, dried under nitrogen and 2 µl of the residue derivatized at room temperature 
with 100 µl of BSTFA+TMCS (Sigma-Aldrich, Italy) injected into the Gas Chromatography/Mass 
Spectrometry (GC/MS) instrument. GC analyses were performed using an Agilent 6890N GC 
equipped with an HP5MS capillary column (0.25 mm × 30 m, film thickness 0.25 ìm) and an 
Agilent mass spectrometer 5973N (Agilent Technologies, Italy). The mass spectrometer was set in 
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EI- single ion monitoring mode (SIM). The ions with m/z of 192 for I.S., 258 for Cr and 225 for 
guanidinoacetic acid (GAA) were used for calculation of the metabolites, using standard curves 
ranging 5–90 µmol/L and 0.30–6 µmol/L for Cr and GAA, respectively. Data were processed by 
the G1701DA MSD ChemStation software. All the aqueous solutions were prepared using ultrapure 
water produced by a Millipore system.   
 
Immunohistochemistry 
Animals were perfused transcardially with 4% paraformaldehyde in phosphate buffer. Brains were 
post-fixed and impregnated with 30% sucrose in phosphate buffered saline (PBS). Coronal brain 
sections (40 µm) were cut on a freezing microtome and collected in PBS before being processed for 
immunohistochemistry. After a blocking step, free-floating slices were incubated O/N at 4°C in a 
solution of primary antibody (NeuN, Millipore, 1:500; Ki67, Abcam, 1:400; DCX, Abcam, 1:200; 
vGlut1, Synaptic System, 1:500; vGAT, Synaptic System, 1:1,000; Iba-1, Wako, 1:400) and 
antigen-antibody interaction was revealed with suitable Alexa Fluor-conjugated secondary 
antibodies (1:400, Invitrogen). Immunostaining for Ki67 involved an additional treatment with 
sodium citrate for antigen retrieval. Sections were then counterstained with Hoechst dye (1: 500, 
Sigma), mounted on microscope slides and coverslipped using Vectashield mounting medium for 
fluorescence (Vector Laboratories Inc.). 
 
Image analysis 
NeuN and Iba1- To quantify the density of neuronal and microglial cells in the cerebral cortex we 
used the StereoInvestigator software (MicroBrightField) equipped with motorized X–Y sensitive 
stage and video camera connected to a computerized image analysis system. NeuN-positive cells 
were counted using 20x magnification and sampling boxes (250 x 250 x 40 µm) located in both 
superficial and deep layers of PFC and ACC cortex. Iba1-positive cells were counted using 40x 
magnification and sampling boxes (250 x 250 x 40 µm) located in both superficial and deep layers 
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of PFC cortex. Cell density was calculated by averaging values obtained from at least 6-8 counting 
boxes per animal. Ki67 and DCX- Examination of Ki67 and DCX-positively labelled cells was 
confined to the hippocampal dentate gyrus (DG), specifically to the granule cell layer (GCL) and 
the subgranular zone of the hippocampus defined as a two-cell body-wide zone along the border 
between the GCL and hilus. Quantification of Ki67 or DCX-immunoreactive cells was conducted 
from 1-in-6 series of immunolabelled sections using 20x magnification and spanning the 
rostrocaudal extent of DG. All immunostained sections were analysed using the StereoInvestigator 
software. The reference volume was determined as the sum of the traced areas multiplied by the 
distance between the sampled sections. Densities of immunopositive cells were then calculated by 
dividing the number of positive cells by the reference volume. Numbers of positively labelled 
neurons were normalized as density per unit of volume (mm3). vGlut1 and vGAT- To quantify the 
density of vGlut1- and vGAT-positive puncta, the parameters of acquisition (laser intensity, gain, 
offset) were optimized at the beginning of the acquisition and then held constant throughout image 
acquisition. All sections were acquired in random order in a single session to minimize fluctuation 
in laser output and degradation of fluorescence. We imaged superficial and deep layers of PFC and 
ACC on a Zeiss laser-scanning Apotome microscope using a 63x oil immersion objective. For each 
section, we imaged serial optical sections at 0.33 µm intervals for a total of at least 15 optical 
sections (5 µm). From each animal we imaged 6 sections (3 in superficial layers and 3 in deep 
layers). Maximum intensity projections (MIPs) were generated from the group of 5 consecutive 
sections yielding the higher mean pixel intensity. These MIPs were imported in ImageJ and 
quantified using Puncta analyzer plugin (61). The number of positive puncta was measured within 
the entire acquired area. 
 
Determination of lipofuscin accumulation by autofluorescence 
Coronal brain sections were mounted on microscope slides and coverslipped using Vectashield 
mounting medium for fluorescence (Vector Laboratories Inc.). We imaged hippocampal DG on a 
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Zeiss laser-scanning Apotome microscope using a 40x oil immersion objective. The parameters of 
acquisition were optimized at the beginning of the experiment and then held constant. Lipofuscin 
level was measured as the presence of autofluorescence at 550 nm in the region of interest. For each 
section, we imaged serial optical sections at 0.5 µm intervals for a total of at least 80 optical 
sections (40 µm). From each animal we imaged 3-4 sections. MIPs were generated from the group 
of 5 consecutive sections yielding the higher mean pixel intensity. These MIPs were imported in 
ImageJ and quantified using Threshold plugin. The area of positive puncta and mean pixel intensity 
were measured within the entire acquired area. 
Statistical analysis 
All statistical analyses were performed using SigmaStat Software. Differences between two groups 
were assessed with a two-tailed t test. The significance of factorial effects and differences among 
more than two groups were evaluated with ANOVA/RM ANOVA followed by Holm-Sidak test. 
Rank transformation was exploited for data not normally distributed. The level of significance was 
p < 0.05.  
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Legends to figures 
Figure 1. Early deficiency of working memory in CrT
–/y
 mice. (a) Schematic diagram of the Y 
maze apparatus. The mean number of entries in the single arms of the maze (A, B, C) and the total 
number of arm entries were comparable for the different experimental groups (Two-Way ANOVA 
on rank transformed data, post hoc Holm-Sidak method, p = 0.506, p = 0.941, p = 0.276, p = 0.391 
respectively).   (b) Alternation rate in the Y maze was significantly lower in CrT–/y mice (n = 9) 
compared to that recorded for CrT+/y littermates (n = 11; t test, p < 0.05) at P28. * p < 0.05. Error 
bars, s.e.m. 
 
Figure 2. Progressive impairment of object recognition memory in CrT
-/y
 mice. Top, a 
schematic representation of the object recognition task. Histograms display object discrimination 
indexes of CrT+/y and CrT-/y during the testing phase performed after a delay of 1 and 24h since the 
sample phase at different ages. (a) P40. While both experimental groups can recognize the new 
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object in the test at 1h (t-test, p = 0.285), a significantly lower discrimination index was found in 
CrT–/y mice (n = 9) compared to CrT+/y animals (n = 7; t-test, p < 0.05). (b) P100. Even if still not 
significant, the recall capacity of CrT–/y animals at 1h was reduced (t test, p = 0.242). At 24h, a t-
test revealed that the performance of CrT–/y animals (n = 11) was strongly impaired with respect to 
controls (n = 10; p < 0.01). (c) P180. A significant deficit of both short (t-test, p < 0.05) and long-
term (t-test, p < 0.05) memory was detected in mutant mice (n = 10) compared to controls (n = 9). * 
p < 0.05; ** p < 0.01. Error bars, s.e.m. 
 
Figure 3. CrT deletion progressively deteriorates spatial learning and memory in mutant 
mice. (a) Left, learning curves for CrT+/y (n = 10, white) and CrT-/y mice (n = 12, grey) at P40. A 
significant difference was detected at day 5 (Two way RM ANOVA, post hoc Holm-Sidak method, 
p < 0.05). Right, histograms showing the mean swimming path covered to locate the submerged 
platform on the last three days of training for the two groups. A significant difference between CrT–
/y and CrT+/y animals was present (t-test, p < 0.01). Representative examples of swimming path 
during the day 3 of the training phase for a CrT+/y (top) and a CrT-/y mouse (bottom) are also 
reported. (b) Left, learning curves for CrT+/y (n = 7, white) and CrT-/y mice (n = 8, grey) at P100. A 
significant difference was detected at day 5 (Two way RM ANOVA, post hoc Holm-Sidak method, 
p < 0.05). Right, histograms showing the mean swimming path on the last three training days for 
the two groups. A significant difference between CrT+/y and CrT-/y animals was present (t-test, p < 
0.05). Representative examples of swimming path during the day 3 of the training phase for a 
CrT+/y (top) and a CrT-/y mouse (bottom) are also reported. (c) Left, learning curves for CrT+/y (n = 
9, white) and CrT-/y mice (n = 7, grey) at P180: mutant mice were poorer learners with respect to 
control littermates and a significant difference was detected at day 3, 4, 5 and 6 (Two way RM 
ANOVA on rank transformed data, post hoc Holm-Sidak method, p < 0.05 for day 3 and 6, p < 0.01 
for day 4 and 5). Right, histograms showing the mean swimming path on the last three day of 
training. A t-test analysis showed a statistical difference between CrT+/y and CrT-/y animals (p < 
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0.01). Representative examples of swimming path during the day 3 of the training phase for a 
CrT+/y (top) and a CrT-/y mouse (bottom) are also depicted. * p < 0.05; # < 0.01. Error bars, s.e.m. 
 
Figure 4. CrT mutation enhance repetitive and stereotyped behaviors. (a) Social interaction 
behaviors in CrT–/y mice. Histograms display discrimination indexes of CrT+/y (n = 6) and CrT-/y (n 
= 8) mice during the social preference (session I) and the social novelty phase (session II). No 
difference was detected between the two groups (Mann-Whitney Rank Sum test, p = 0.662 for 
session I; t-test, p = 0.784 for session II). A schematic representation of the three-chamber test is 
also depicted. (b) Performance of littermate wild-type (n = 11) and CrT–/y mice (n = 9) on the 
accelerating rotarod. Inset shows an illustration of the rotarod apparatus. A Two Way ANOVA 
showed a significant effect of genotype (p < 0.001). Post hoc Holm-Sidak test revealed that the fall 
latency of mutant animals was significantly different from that of wild-type mice at all ages tested 
(p < 0.01 at P40 and P100, p < 0.05 at P180). A schematic representation of the rotarod test is also 
depicted. (c) Histograms display mean time spent self-grooming in CrT+/y and CrT-/y animals at P40 
and P180. While no difference was detected at P40 (CrT+/y, n = 7; CrT–/y, n = 9; Two Way ANOVA 
on rank transformed data, post hoc Holm Sidak method, p = 0.912), CrT null mice exhibit increased 
grooming behavior at P180 (CrT+/y, n = 11; CrT–/y, n = 7; p < 0.01). A schematic representation of 
self-grooming behavior is reported.* p < 0.05; # < 0.01. Error bars, s.e.m. 
   
Figure 5. Synaptic neurotransmission in CrT
+/y
 and CrT
-/y
 animals at P180. (a) Left, 
representative immunostaining for vGlut1 from PFC and ACC of a CrT+/y and a CrT-/y mouse. 
Right, no difference in vGlut1 staining was detected between the two experimental groups (n = 6 
for both groups) either in PFC  (t-test, p = 0.792) or ACC (t-test, p = 0.340). (b) Left, representative 
immunostaining for vGAT from PFC and ACC of a CrT+/y and a CrT-/y mouse. The number of 
vGAT-positive puncta was significantly reduced both in the PFC and the ACC of mutant animals (n 
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= 9) with respect to controls (n = 8; t-test, p < 0.05 for both comparisons). * p < 0.05. Calibration 
bars: 25 µm. Error bars, s.e.m. 
 
Figure 6. Pathological activation of microglial cells in CrT
−/y
 animals (a) Left, representative 
immunostaining for Iba1 from prefrontal cortex (PFC) of a CrT+/y and a CrT-/y mouse. Right, a 
significant increase of the percentage of activated microglial cells, with a parallel decrease of 
resting microglia, was detected in mutant mice with respect to wild-type animals (n = 8 for both 
groups; Two Way ANOVA, post hoc Holm Sidak method, p < 0.01). (b) Left, representative 
immunostaining for Iba1 from the hippocampus (HP) of a CrT+/y and a CrT-/y mouse. Right, the 
percentage of activated microglia was increased in mutant mice, whereas the relative number of 
resting cells was reduced compared to controls (n = 8 for both groups; Two Way ANOVA, post hoc 
Holm Sidak method, p < 0.05). * p < 0.05; ** p < 0.01. Calibration bar: 100 µm. Error bars, s.e.m. 
 
Figure 7. Neurogenesis impairment and enhanced lipofuscin accumulation in the 
hippocampus of CrT
−/y
 animals at P180. (a) The hippocampal volume of CrT-/y mice was smaller 
compared to CrT+/y mice (n = 6 for both groups; t-test, p < 0.05). (b) Stereological counting 
revealed that the density of Ki67-positive cells was significantly reduced in the DG of CrT-/y mice, 
with approximately 30% reduction with respect to wild-type littermates (n = 6 for both groups; t- 
test, p < 0.01). (c) A significant decrease of the DCX-positive immature neurons was detected in the 
hippocampus of adult CrT-/y mice compared to controls (n = 6 for both groups; t-test, p < 0.001). (d) 
Representative immunostaining for Ki-67, a nuclear protein required for cellular proliferation, from 
a CrT+/y and a CrT-/y mouse. (e) Representative immunostaining for DCX, a microtubule-associated 
phosphoprotein expressed in early neuronal differentiation, from a CrT+/y and a CrT-/y mouse. (f) 
Representative images for lipofuscin autofluorescence from a CrT+/y and a CrT-/y mouse. (g) Six-
month-old CrT-/y mice (n = 6) show extensive accumulation of autofluorescent material throughout 
the brain when compared to the wild-type control (n = 5). A significant increase of abnormal 
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autofluorescent storage was mainly found in DG granular and polymorph layer of CrT-/y mice (t-
test, p < 0.05). * p < 0.05; ** p < 0.01; *** p < 0.001. Calibration bars: 50 µm. Error bars, s.e.m. 
 
Figure 8. A selective brain deletion of CrT is sufficient to impair cognitive functions and 
hippocampal neurogenesis. (a) Histograms display object discrimination indexes of nes-CrT+/y 
and nes-CrT-/y during the testing phase performed after a delay of 1 and 24h since the sample phase 
at P180. A significant deficit of both short (t-test, p < 0.05) and long-term (t-test, p < 0.05) memory 
was detected in mutant mice (n = 6) compared to controls (n = 8). (b) Alternation rate in the Y maze 
was significantly lower in nes-CrT–/y mice (n = 6) compared to that recorded for nes-CrT+/y 
littermates (n = 9; t test, p < 0.05) at P180. (c) A significant decrease of the Ki67-positive cells was 
detected in the hippocampus of P180 nes-CrT-/y mice compared to age-matched controls (n = 6 for 
both groups; t-test, p < 0.05).  * p < 0.05. Error bars, s.e.m. 
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Tissue (nmol/mg protein) 
P30 P180 
CrT
+/y CrT-/y CrT+/y CrT-/y 
Cerebral cortex 76.36 ± 3.16 13.61 ± 1.06*** 92.41 ± 0.66 14.15 ± 0.66*** 
Hippocampus 83.69 ± 4.37 14.14 ± 1.52*** 88.73 ± 4.97 14.79 ± 1.46*** 
Muscle 310.20 ± 31.59 111.57 ± 21.27*** 365.38 ± 8.19 15.94 ± 5.55*** 
Heart 89.92 ± 5.15 1.19 ± 0.27*** 100.91 ± 3.36 2.39 ± 0.61*** 
Kidney 9.60 ± 0.65 1.59 ± 0.13* 10.36 ± 0.80 1.80 ± 0.78** 
 
Table 1. Cr levels (mean ± SEM) in CrT
+/y
 and CrT
-/y
 animals at P30 and P180 (n = 4 per tissue 
for both groups). Cr levels have been measured by GC/MS. A reduction of Cr content was evident 
in the brain, muscle, heart and kidney of mutant animals at both P30 and P180 (Two Way ANOVA 
on rank transformed data, post hoc Holm-Sidak method). * p < 0.05; ** p < 0.01; *** p < 0.001.  
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Tissue (nmol/mg protein) 
P30 P180 
CrT
+/y CrT-/y CrT+/y CrT-/y 
Cerebral cortex 0.060 ± 0.002 0.114 ± 0.016*** 0.050 ± 0.006 0.066 ± 0.005 
Hippocampus 0 0.091 ± 0.007 *** 0.026 ± 0.015 0.079 ± 0.009** 
Muscle 0.106 ± 0.006 0.282 ± 0.068** 0.026 ± 0.010 0.150 ± 0.050** 
Heart 0.094 ± 0.010 0.060 ± 0.004*** 0.052 ± 0.007 0.033 ± 0.015 
Kidney 10.700 ± 0.627 9.758 ± 0.712 2.205 ± 0.259 2. 411 ± 0.112 
 
Table 2. GAA levels (mean ± SEM) in CrT
+/y
 and CrT
-/y
 animals at P30 and P180 (n = 4 per 
tissue for both groups). At P30, a moderate increase of GAA content was evident in the brain and 
the muscle of mutant animals (Two Way ANOVA on rank transformed data, post hoc Holm-Sidak 
method, p < 0.05), whereas GAA was decreased in the heart of CrT–/y animals (p < 0.05) and no 
difference was detected in the kidney tissue (p = 0.359). At P180, GAA levels were higher in the 
hippocampus and the muscle of mutant animals (Two Way ANOVA on rank transformed data, post 
hoc Holm-Sidak method, p < 0.01), whereas no difference was detected in cortex, heart and kidney 
(p = 0.175, p = 0.320 and p = 0.920, respectively). ** p < 0.01; *** p < 0.001. 
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Tissue (nmol/mg protein) nes-CrT+/y nes-CrT-/y CrTfl/y 
Cerebral cortex 73.29 ± 1.88 17.36 ± 0.87*** 71.55 ± 4.15 
Hippocampus 87.45 ± 4.17 17.13 ± 2.22 *** 94.62 ± 4.35 
Muscle 382.97 ± 20.46 390.58  ± 22.66 385.36 ± 27.59 
Heart 78.24 ± 3.72 70.35 ± 3.10 68.02 ± 1.79 
Kidney 6.10 ± 0.81 3.11 ± 0.27 7.60 ± 1.22 
 
 
Table 3. Cr levels (mean ± SEM) in nes-CrT
+/y
, nes-CrT
-/y
 and CrT
fl/y
 animals at P180 (n = 4 
per tissue for all groups). A reduction of Cr content was evident in the brain of mutant animals, 
while peripheral tissues were not affected (Two Way ANOVA on rank transformed data, post hoc 
Holm-Sidak method). *** p < 0.001.  
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Tissue (nmol/mg protein) nes-CrT+/y nes-CrT-/y CrTfl/y 
Cerebral cortex 0.048 ± 0.005 0.059 ± 0.004*** 0.048 ± 0.004 
Hippocampus 0.068 ± 0.005 0.131 ± 0.018* 0.074 ± 0.011 
Muscle 0.054 ± 0.006 0.061 ± 0.002 0.059 ± 0.003 
Heart 0.045 ± 0.004 0.047 ± 0.003 0.054 ± 0.007 
Kidney 1.705 ± 0.373 1.231 ± 0.099 3.051 ± 0.914 
 
Table 4. GAA levels (mean ± SEM) in nes-CrT
+/y
, nes-CrT
-/y
 and CrT
fl/y
 animals at P180 (n = 4 
per tissue for all groups). An increase of GAA content was evident in the brain of mutant animals, 
while peripheral tissues were not affected (Two Way ANOVA on rank transformed data, post hoc 
Holm-Sidak method). * p < 0.05; *** p < 0.001.  
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Point to point response letter to the Reviewers’ comments: 
In the revised version of the manuscript, corrections to the former manuscript have been highlighted 
in yellow to simplify the reviewing process. 
 
Response to Reviewer #1: (reviewer’s comments are in italics) 
This is a very well designed study in a creatine transporter deficient mouse model demonstrating a 
variety of cognitive and behavioral abnormalities in the knock-out model. Most importantly the 
study points to early brain aging associated with creatine depletion. The manuscript is well written 
and the conclusions are reasonable. Would be nice to have a bit more of a discussion about the fact 
that younger mice are not as creatine depleted in the muscle as compared to older age (P180).  
 
We discussed the difference in muscular Cr levels between young (P30) and adult (P180) mice (p. 
15). We detected a significant reduction of Cr levels in P180 CrT-/y mice with respect to P30 CrT 
null mice only at level of muscular tissue, indicating that the compensatory upregulation of Cr 
biosynthesis in the muscle declines with age. Despite the ubiquitary pattern of CrT deletion, only 
few CCDS1 patients displayed an alteration of muscular Cr levels and strength (Puusepp et al., 
2010). Our results raise the possibility that a muscular phenotype could occur also in patients later 
in life. 
 
Also adding the guanidinoacetate concentrations to the table (why is this a figure 5?) would be 
helpful, instead of putting it in the supplement.  
 
We included the results about guanidinoacetate levels in the main body of the manuscript (Table 2), 
as suggested by the reviewer. Figure 5 is now Table 1. 
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BTW, the mouse chow (4RF21 GFP, Mucedola) is composed of 3.5% animal protein; therefore it is 
NOT a creatine free chow. The statement ‘the chow was not added with Cr (personal 
communication of the manufacturer) (P17, l 13) is misleading.  
 
We removed the misleading sentence as suggested by the reviewer. 
 
Response to Reviewer #2: 
The creatine transporter (CrT) deficiency is an X-linked inherited neurometabolic disorder 
characterized by severe intellectual disability, epilepsy and autistic behaviors. The syndrome, 
caused by mutations in SLC6A8, the creatine transporter 1 protein gene, is currently untreatable 
due to the fact that creatine cannot pass the blood barrier. Very little is known on how deficiency in 
brain creatine affects the development of neuronal circuits and their function in adulthood. In the 
present manuscript, Baroncelli and colleagues provided significant novel data pointing to 
important insights in the cellular and molecular mechanisms underlying the progression of the 
disorder in the CrT mutant mice. The authors performed a longitudinal evaluation of cognitive 
functions in CrT deficient mice and analyzed aging-related markers including synaptic number, 
neuronal degeneration, hippocampal neurogenesis and neuroinflammation. They found a 
progressive worsening of cognition as evaluated by novel object recognition, Y maze and Morris 
Water Maze starting as early as postnatal day 28 until P180. At the cellular level, the authors 
revealed a significant reduction of vGAT but not vGlut1 positive synapses across cortical layers 
suggesting compromised inhibitory circuits. This was also accompanied by increased activated 
microglia as indicated by iba-1 elevated expression, accumulation of autofluorescent lipofuscin 
mainly in the dentate gyrus of hippocampus and reduced neurogenesis. The authors concluded that 
loss of creatine induces precocious aging of neuronal circuits and progressive worsening of 
cognitive performances. 
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The manuscript is well written, organized and the experiments are well executed with a significant 
number of animals in each group and proper statistical analysis performed. The results are novel 
and relevant.  
 
There are only few points that the authors should address before the manuscript is suitable for 
publication in Human Molecular Genetics. 
1) It is important to keep in mind that in humans, the CNS is the main organ affected by creatine 
deficiency syndrome. Indeed patients appear to have normal cardiac function and normal creatine 
levels in the muscles. This is different from what the authors report here in the mouse model. 
Therefore, it is important to understand whether a selective deletion of CrT in neuron would be 
sufficient to recapitulate the cognitive and cellular defects described in the global deletion model. 
The authors do not need to repeat the complete set of experiments performed in the total KO. 
Rather they could focus in adulthood and perform cognitive behavioral evaluation together with 
analysis of GABA circuits, microglia activation accumulation of lipofuscin. 
 
We totally agree with the reviewer about the importance to understand whether a selective deletion 
of CrT in the central nervous system could be sufficient to recapitulate the phenotype displayed by 
the ubiquitary knock-out model. Indeed, we had already developed a mouse carrying a floxed 
Slc6a8 gene. To target CrT deletion to neuronal and glial precursors widespread in the nervous 
system, we crossed the floxed Slc6a8 mouse with the Nestin::Cre recombinase mouse Tg(Nes-
cre)1Kln mouse from Jackson (http://jaxmice.jax.org/strain/003771.html). The resulting neural 
specific KO displayed a selective loss of Cr and a slight GAA upregulation in cortex and 
hippocampus but normal Cr levels in the periphery (Table 3, 4). Our behavioral investigation 
highlighted that mutant (nes-CrT-/y) animals showed an impaired performance in the object 
recognition test and a lower alternation rate in the Y maze, demonstrating an impairment of both 
declarative and working memory reminiscent of the deficit described in the ubiquitary model. We 
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also investigated whether selective CrT deficiency could affect hippocampal neurogenesis. 
Stereological analysis revealed that the number of Ki67-positive cell was significantly lower in the 
DG of nes-CrT−/y animal at P180. These results prove that the lack of CrT protein exclusively 
restricted to brain cells is sufficient to recapitulate the cognitive and cellular defects displayed by 
global knock-out mice. We included this new set of data in the manuscript by adding a new 
paragraph in the result section and by presenting Figure 8. We also included a new paragraph in the 
method section describing generation and genotyping of conditional CrT−/y animals, and we 
discussed these new results. 
 
2) The immunohistochemistry analysis of synaptic markers, microglia activation, neurogenesis, 
were all performed at P180. These are very important data, however still do not tell us whether 
these defects precede or accompany the onset of behavioral defects the author found already in the 
juvenile animals. At a minimum, the authors should repeat the analysis at younger ages (P28 
and/or P40) and compare the results with P180. In addition to corroborate the conclusion of 
premature aging in CrT mice, the authors should analyze older control mice (>one year). 
 
We agree with the reviewer that a comparative analysis of synaptic markers, microglia activation 
and neurogenesis in young and adult animals would increase the knowledge about cellular defects 
underlying the onset and progression of pathological behavioral phenotype of CrT null mice. At 
present, however, we do not have samples from young animals in storage and the length of time 
required to obtain a sufficient number of CrT−/y and CrT+/y for this analysis would considerably 
exceed the deadline for manuscript revision. Future studies will need to check the developmental 
profile of markers modifications. We acknowledged this point in the discussion.  
 
To further corroborate the hypothesis of a premature cognitive decline in CrT null mice, we 
compared the performance in the MWM of P180 CrT−/y animals and one-year old wild-type mice. 
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The mean distance to locate the platform on the last three days of training and the probe test 
revealed a similar memory impairment in these two experimental groups. We included this new set 
of data in the manuscript by adding a new paragraph in the Result section and by presenting Figure 
S5.  
 
Minor point: 
1) The color scheme used (white= mutant; grey = wild type) and the scheme presentation (first 
mutant then control) make difficult to understand the results presented. I suggest to switch to white 
for WT and solid color for the mutant and switch the order of the data, plotting first the control and 
then the CrT-/y. 
 
We changed the color scheme and the scheme presentation of figures as suggested by the reviewers. 
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Figure 1. Early deficiency of working memory in CrT–/y mice. (a) Schematic diagram of the Y maze 
apparatus. The mean number of entries in the single arms of the maze (A, B, C) and the total number of 
arm entries were comparable for the different experimental groups (Two-Way ANOVA on rank transformed 
data, post hoc Holm-Sidak method, p = 0.506, p = 0.941, p = 0.276, p = 0.391 respectively).   (b) 
Alternation rate in the Y maze was significantly lower in CrT–/y mice (n = 9) compared to that recorded for 
CrT+/y littermates (n = 11; t test, p < 0.05) at P28. * p < 0.05. Error bars, s.e.m.  
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Figure 2. Progressive impairment of object recognition memory in CrT-/y mice. Top, a schematic 
representation of the object recognition task. Histograms display object discrimination indexes of CrT+/y 
and CrT-/y during the testing phase performed after a delay of 1 and 24h since the sample phase at 
different ages. (a) P40. While both experimental groups can recognize the new object in the test at 1h (t-
test, p = 0.285), a significantly lower discrimination index was found in CrT–/y mice (n = 9) compared to 
CrT+/y animals (n = 7; t-test, p < 0.05). (b) P100. Even if still not significant, the recall capacity of CrT–/y 
animals at 1h was reduced (t test, p = 0.242). At 24h, a t-test revealed that the performance of CrT–/y 
animals (n = 11) was strongly impaired with respect to controls (n = 10; p < 0.01). (c) P180. A significant 
deficit of both short (t-test, p < 0.05) and long-term (t-test, p < 0.05) memory was detected in mutant 
mice (n = 10) compared to controls (n = 9). * p < 0.05; ** p < 0.01. Error bars, s.e.m.  
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Figure 3. CrT deletion progressively deteriorates spatial learning and memory in mutant mice. (a) Left, 
learning curves for CrT+/y (n = 10, white) and CrT-/y mice (n = 12, grey) at P40. A significant difference 
was detected at day 5 (Two way RM ANOVA, post hoc Holm-Sidak method, p < 0.05). Right, histograms 
showing the mean swimming path covered to locate the submerged platform on the last three days of 
training for the two groups. A significant difference between CrT–/y and CrT+/y animals was present (t-test, 
p < 0.01). Representative examples of swimming path during the day 3 of the training phase for a CrT+/y 
(top) and a CrT-/y mouse (bottom) are also reported. (b) Left, learning curves for CrT+/y (n = 7, white) 
and CrT-/y mice (n = 8, grey) at P100. A significant difference was detected at day 5 (Two way RM ANOVA, 
post hoc Holm-Sidak method, p < 0.05). Right, histograms showing the mean swimming path on the last 
three training days for the two groups. A significant difference between CrT+/y and CrT-/y animals was 
present (t-test, p < 0.05). Representative examples of swimming path during the day 3 of the training 
phase for a CrT+/y (top) and a CrT-/y mouse (bottom) are also reported. (c) Left, learning curves for 
CrT+/y (n = 9, white) and CrT-/y mice (n = 7, grey) at P180: mutant mice were poorer learners with 
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respect to control littermates and a significant difference was detected at day 3, 4, 5 and 6 (Two way RM 
ANOVA on rank transformed data, post hoc Holm-Sidak method, p < 0.05 for day 3 and 6, p < 0.01 for day 
4 and 5). Right, histograms showing the mean swimming path on the last three day of training. A t-test 
analysis showed a statistical difference between CrT+/y and CrT-/y animals (p < 0.01). Representative 
examples of swimming path during the day 3 of the training phase for a CrT+/y (top) and a CrT-/y mouse 
(bottom) are also depicted. * p < 0.05; # < 0.01. Error bars, s.e.m.  
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Figure 4. CrT mutation enhance repetitive and stereotyped behaviors. (a) Social interaction behaviors in 
CrT–/y mice. Histograms display discrimination indexes of CrT+/y (n = 6) and CrT-/y (n = 8) mice during 
the social preference (session I) and the social novelty phase (session II). No difference was detected 
between the two groups (Mann-Whitney Rank Sum test, p = 0.662 for session I; t-test, p = 0.784 for 
session II). A schematic representation of the three-chamber test is also depicted. (b) Performance of 
littermate wild-type (n = 11) and CrT–/y mice (n = 9) on the accelerating rotarod. Inset shows an 
illustration of the rotarod apparatus. A Two Way ANOVA showed a significant effect of genotype (p < 0.001). 
Post hoc Holm-Sidak test revealed that the fall latency of mutant animals was significantly different from 
that of wild-type mice at all ages tested (p < 0.01 at P40 and P100, p < 0.05 at P180). A schematic 
representation of the rotarod test is also depicted. (c) Histograms display mean time spent self-grooming in 
CrT+/y and CrT-/y animals at P40 and P180. While no difference was detected at P40 (CrT+/y, n = 7; CrT–
/y, n = 9; Two Way ANOVA on rank transformed data, post hoc Holm Sidak method, p = 0.912), CrT null 
mice exhibit increased grooming behavior at P180 (CrT+/y, n = 11; CrT–/y, n = 7; p < 0.01). A schematic 
representation of self-grooming behavior is reported.* p < 0.05; # < 0.01. Error bars, s.e.m.  
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Figure 5. Synaptic neurotransmission in CrT+/y and CrT-/y animals at P180. (a) Left, representative 
immunostaining for vGlut1 from PFC and ACC of a CrT+/y and a CrT-/y mouse. Right, no difference in 
vGlut1 staining was detected between the two experimental groups (n = 6 for both groups) either in PFC  (t-
test, p = 0.792) or ACC (t-test, p = 0.340). (b) Left, representative immunostaining for vGAT from PFC and 
ACC of a CrT+/y and a CrT-/y mouse. The number of vGAT-positive puncta was significantly reduced both in 
the PFC and the ACC of mutant animals (n = 9) with respect to controls (n = 8; t-test, p < 0.05 for both 
comparisons). * p < 0.05. Calibration bars: 25 µm. Error bars, s.e.m.  
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Figure 6. Pathological activation of microglial cells in CrT−/y animals (a) Left, representative 
immunostaining for Iba1 from prefrontal cortex (PFC) of a CrT+/y and a CrT-/y mouse. Right, a significant 
increase of the percentage of activated microglial cells, with a parallel decrease of resting microglia, was 
detected in mutant mice with respect to wild-type animals (n = 8 for both groups; Two Way ANOVA, post 
hoc Holm Sidak method, p < 0.01). (b) Left, representative immunostaining for Iba1 from the hippocampus 
(HP) of a CrT+/y and a CrT-/y mouse. Right, the percentage of activated microglia was increased in mutant 
mice, whereas the relative number of resting cells was reduced compared to controls (n = 8 for both 
groups; Two Way ANOVA, post hoc Holm Sidak method, p < 0.05). * p < 0.05; ** p < 0.01. Calibration 
bar: 100 µm. Error bars, s.e.m.  
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Figure 7. Neurogenesis impairment and enhanced lipofuscin accumulation in the hippocampus of CrT−/y 
animals at P180. (a) The hippocampal volume of CrT-/y mice was smaller compared to CrT+/y mice (n = 6 
for both groups; t-test, p < 0.05). (b) Stereological counting revealed that the density of Ki67-positive cells 
was significantly reduced in the DG of CrT-/y mice, with approximately 30% reduction with respect to wild-
type littermates (n = 6 for both groups; t- test, p < 0.01). (c) A significant decrease of the DCX-positive 
immature neurons was detected in the hippocampus of adult CrT-/y mice compared to controls (n = 6 for 
both groups; t-test, p < 0.001). (d) Representative immunostaining for Ki-67, a nuclear protein required for 
cellular proliferation, from a CrT+/y and a CrT-/y mouse. (e) Representative immunostaining for DCX, a 
microtubule-associated phosphoprotein expressed in early neuronal differentiation, from a CrT+/y and a 
CrT-/y mouse. (f) Representative images for lipofuscin autofluorescence from a CrT+/y and a CrT-/y mouse. 
(g) Six-month-old CrT-/y mice (n = 6) show extensive accumulation of autofluorescent material throughout 
the brain when compared to the wild-type control (n = 5). A significant increase of abnormal autofluorescent 
storage was mainly found in DG granular and polymorph layer of CrT-/y mice (t-test, p < 0.05). * p < 0.05; 
** p < 0.01; *** p < 0.001. Calibration bars: 50 µm. Error bars, s.e.m.  
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Figure 8. A selective brain deletion of CrT is sufficient to impair cognitive functions and hippocampal 
neurogenesis. (a) Histograms display object discrimination indexes of nes-CrT+/y and nes-CrT-/y during the 
testing phase performed after a delay of 1 and 24h since the sample phase at P180. A significant deficit of 
both short (t-test, p < 0.05) and long-term (t-test, p < 0.05) memory was detected in mutant mice (n = 6) 
compared to controls (n = 8). (b) Alternation rate in the Y maze was significantly lower in nes-CrT–/y mice 
(n = 6) compared to that recorded for nes-CrT+/y littermates (n = 9; t test, p < 0.05) at P180. (c) A 
significant decrease of the Ki67-positive cells was detected in the hippocampus of P180 nes-CrT-/y mice 
compared to age-matched controls (n = 6 for both groups; t-test, p < 0.05).  * p < 0.05. Error bars, s.e.m. 
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